Showing posts with label CDRH. Show all posts
Showing posts with label CDRH. Show all posts

USFDA CDRH - List of Medical Devices Cleared/Approved in the 2014...

The products listed in this section include some of the newest medical technology from the year 2014. 

The products in each list contain information about what medical uses the device is cleared or approved for, when it can be used, and when it should not be used. 

This information, along with information from your doctor and other sources, can help make you an informed participant in your health care.


Medical Devices Cleared or Approved by FDA in 2014


Device NameCategoryDate
Medtronic IN.PACT Admiral Paclitaxel-coated PTA Balloon Catheter - P140010 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter 12/30/14
Bellafill PMMA Collagen Dermal Filler - P020012/S009 Dermal filler 12/23/14
BRACAnalysis CDx - P140020 Ovarian Cancer 12/19/14
TECNIS Multifocal 1-Piece Intraocular Lens (IOL), Models ZKB00 (+2.75 D) and ZLB00 (+3.25 D) - P980040/S049 Artificial Lenses 12/17/14
Barostim neo Legacy System - H130007 Implantable Pulse Generator (IPG) 12/12/14
Animas Vibe System - P130007 Glucose Monitoring 11/25/14
IDEAL IMPLANT Saline-filled Breast Implant - P120011 Breast Implants 11/14/14
TactiCath Quartz Contact Force Ablation Catheter and TactiSys Quartz Equipment - P130026 Catheter 10/24/14
Dexcom G4 PLATINUM Continuous Glucose Monitoring System - P120005/S018 Glucose Monitoring 10/21/14
EverFlex Self-Expanding Peripheral Stent System – P110023/S007 Stent 10/10/14
Lutonix 035 Drug Coated Balloon PTA Catheter - P130024 Angioplasty 10/09/14
XIENCE Family of Everolimus Eluting Coronary Stent Systems - P070015/S122 and P110019/S066 Stent 10/03/14
GORE VIABAHN Endoprosthesis, GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface - P040037/S060 Stent 09/19/14
SenoClaire - P130020 Mammography 08/26/14
Pleximmune - H130004 Blood Test 08/26/14
XPS System with STEEN Solution Perfusate - H120003 Lung Transplant 08/12/14
Cologuard - P130017 Stool Test 08/11/14
Low-Profile Visualized Intraluminal Support Device (LVIS and LVIS Jr.) - H130005 Stent 07/25/14
Prestige LP Cervical Disc - P090029 Cervical Disc 07/24/14
REBEL Platinum Chromium Coronary Stent System (Monorail and Over-the-Wire) - P130030 Stent 06/27/14
Sorin Freedom SOLO Stentless Heart Valve and SOLO Smart Stentless Heart Valve - P130011 Stentless Heart Valve 06/24/14
Fluency Plus Endovascular Stent Graft - P130029 Endovascular Stent Graft 06/17/14
Edwards SAPIEN XT Transcatheter Heart Valve - P130009 Heart Valve 06/16/14
Restylane Silk Injectable Gel - P040024/S072 Injection 06/13/14
Medtronic CoreValve System - P130021/S002 Aortic Heart Valve 06/12/14
artus CMV RGQ MDx Kit - P130027 Cytomegalovirus (CMV) DNA Test 06/02/14
CardioMEMS HF System - P100045 Pulmonary Artery Pressure 05/28/14
therascreen KRAS RGQ PCR Kit - P110027 Automated Molecular Assay 05/23/14
ADVIA Centaur® HBsAgII - P110041 hepatitis B virus (HBV) 05/16/14
GEL-SYN - P110005 Osteoarthritis 05/09/14
Inspire Upper Airway Stimulation - P130008 Obstructive Sleep Apnea 04/30/14
cobas® HPV Test - P100020/S008 HPV Test 04/24/14
Medtronic CRT-P and CRT-D Devices - P010015/S205 and P010031/S381 Pacemaker/Defibrillator 04/10/14
Supera Peripheral Stent System – P120020 Peripheral Stent 03/28/14
Nucleus® Hybrid™ L24 Cochlear Implant System – P130016 Cochlear Implant System 03/20/14
Elecsys® HBeAg Immunoassay and Elecsys® PreciControl HBeAg - P130015 Hepatitis B Test 03/14/14
MONOVISC™ - P090031 Joints 02/25/14
Dexcom G4 PLATINUM (Pediatric) Continuous Glucose Monitoring System - P120005/S002 Glucose Monitoring 02/03/14
Medtronic Valiant Thoracic Stent Graft with Captivia Delivery System - P100040/S012 Stent Graft 01/22/14
Medtronic CoreValve System - P130021 Artificial aortic valve 01/17/14
ReSure® Sealant - P130004 Surgical Sealant 01/08/14

USFDA - Deadline for Registration and Listing of Medical Devices Manufacturers...


It’s registration and listing time!  All medical device establishments are required to pay the annual registration user fee and re-register their establishments by December 31, 2014.
FDA’s Center for Devices and Radiological Health (CDRH) has a new  tutorial that explains how to register a domestic establishment for the first time in the FURLS (FDA’s Unified Registration and Listing System)/Device Registration and Listing Module (DRLM).  

You can access this tutorial and other registration and listing tutorials through the CDRH Learn website under the “Start Here/The Basics!” section. 

USFDA CDRH MEDICAL DEVICES WEBINARS : Download CDRH Industry Basics Workshop (All Day Webinars) – November 4, 2014

Date: 5th Nov 2014
Webinar: CDRH Industry Basics Workshop
Summary: This workshop (presented by webinar) will provide information on the fundamental concepts of medical device regulations.
The workshop will feature five sessions, each of which will consist of a presentation followed by a question and answer session with a panel of experts. Participants will be able to email or call us with your questions during each session.
Participants can choose to participate in any and/or all of the sessions. Each session will begin precisely at the scheduled time. Click link to view.download printable slides of respective webinar
Target Audience included experts and professionals from Medical Device Industry, Medical Device Developers, Medical Device Industry Associations.

USFDA CDRH Webinar on Distinguishing Medical Device Recalls from Medical Device Enhancements conducted on 5th Nov 2014..

Webinar: Distinguishing Medical Device Recalls from Medical Device Enhancements – Final Guidance

Summary: The guidance clarifies for manufacturers how to determine when changes to a device constitute a recall and when they are considered a product enhancement.
The guidance contains clear definitions and practical examples to help manufacturers distinguish a recall from an enhancement. Correctly identifying a change to a device as a recall reduces the time between identification of a device defect/failure and public notification.

Clarifying when a change to a device represents a recall or an enhancement will help manufacturers better understand when reporting device changes to the FDA is required.

View/Download Printable Slides of the Webinar CLICK HERE

USFDA CDRH Medical Device Safety and Recalls: Covidien, Medi-Trace Cadence and Kendall Defibrillation Electrodes...

A recall has been issued for the Covidien Medi-Trace Cadence and Kendall Defibrillation Electrodes because the electrodes will not work with Philips FR3 and FRx Automated External Defibrillators.  
Philips made changes to the design of their connectors for the FR3 and FRx AEDs, and because of these changes, the Covidien defibrillation electrodes will not work with these AEDs.  Use of these electrodes could cause a delay in delivering electrical therapy that is needed to revive patients. Additionally, their use could lead to severe health problems such as stroke, organ failure, or death if alternative defibrillator electrodes are not readily available. Covidien received two reports of injuries. There was a delay in resuscitating one patient which may have contributed to the subsequent death of the patient.  

USFDA CDRH Industry Basics Workshops All Day Webinar on Nov 4, 2014

Webinar: CDRH Industry Basics Workshop
Summary: This workshop (presented by webinar) will provide information on the fundamental concepts of medical device regulations.
The workshop will feature five sessions, each of which will consist of a presentation followed by a question and answer session with a panel of experts. Participants will be able to email or call us with your questions during each session.
Participants can choose to participate in any and/or all of the sessions. Each session will begin precisely at the scheduled time.
  • 10:00-11:00 am: Investigational Device Exemption (IDE) Program
  • 11:00-12:00 noon: 510(k) Program
  • 12:00-1:00 pm: De Novo
  • 2:00-3:00 pm: Corrective and Preventive Actions (CAPA)
  • 3:00-4:00 pm: Electronic Medical Device Reporting (eMDR)
Target Audience: Medical Device Industry, Medical Device Developers, Medical Device Industry Associations
Webinar Details
Date: November 4, 2014 
Time: 10:00 AM – 4:00 PM, Eastern Time – To ensure you are connected, log-in by 9:45 AM.
Webinar Link: http://fda.yorkcast.com/webcast/play/c369da3174e945db99747267beeb2a551d
Audio Dial-In: 800-527-1401 (to ask questions during the Q&A sessions)

USFDA : Draft Guidance for Industry : Content and Format for Abbreviated 510(k)s for Early Growth Response 1 (EGR1) Gene Fluorescence In-Situ Hybridization (FISH) Test System for Specimen Characterization Devices



A draft guidance has been posted titled, "Content and Format for Abbreviated 510(k)s for Early Growth Response 1 (EGR1) Gene Fluorescence In-Situ Hybridization (FISH) Test System for Specimen Characterization Devices."  FDA is issuing this guidance to provide industry and agency staff with recommendations for 100 the suggested format and content of an Abbreviated 510(k) submission for early growth 101 response 1 (EGR1) gene fluorescence in-situ hybridization (FISH) test system for specimen 102 characterization devices and recommendations for addressing certain labeling issues relevant 103 to the review process specific to these devices.  

To view/download the draft guidance, please CLICK HERE

USFDA CDRH Webinar on "Medical Devices in the Home: Design Considerations and Guidance for Industry"

USFDA CDRH has uploaded recorded webinar, printable slides and transcript for the Webinar

"Medical Devices in the Home: Design Considerations and Guidance for Industry"

Please view/download

Recorded Webinar

Printable Slides (PDF)

Transcripts (PDF)

For other webinars posted by CDRH on Medical Devices - CLICK HERE

USFDA CDRH Transcript for Webinar "FDA Decisions for Investigational Device Exemption (IDE) Clinical Investigations"

USFDA CDRH has uploaded printable slides and transcript for the webinar "FDA Decisions for Investigational Device Exemption (IDE) Clinical Investigations" conducted on 4th SEP 2014.

For Recorded Webinar Video CLICK HERE
For Printable Slides Download CLICK HERE
For Transcript Download CLICK HERE

USFDA CDRH New Device Approvals: XPS System with STEEN Solution Perfusate...

Picture of the device.

The FDA has recently approved the XPS System with STEEN Solution Perfusate to be marketed.  The XVIVO Perfusion System (XPS) with STEEN Solution Perfusate preserves donated lungs that do not initially meet the standard criteria for lung transplantation but may be transplantable if there is more time to observe and evaluate the organ’s function. 


Product Name: XVIVO Perfusion System (XPS) with STEEN Solution Perfusate
HDE Applicant: XVIVO Perfusion, Inc.
Address:  3666 S Inca Street, Englewood, CO  80110
Approval Date: August 12, 2014
Approval Letter: http://www.accessdata.fda.gov/cdrh_docs/pdf12/H120003a.pdf
What is it?  The XVIVO Perfusion System (XPS) with STEEN Solution Perfusate preserves donated lungs that do not initially meet the standard criteria for lung transplantation but may be transplantable if there is more time to observe and evaluate the organ’s function.
The XPS System consists of hardware, software, STEEN solution, tubing sets, and an organ chamber. The XPS System houses the organ for preservation and perfuses it with a preservation solution, during which time the lungs can be assessed by the transplant surgeon. The STEEN Solution temporarily maintains the isolated lungs after removal from the donor.
When is it used?  The XPS System with STEEN Solution Perfusate is used to flush and preserve initially unacceptable donor lungs after removal and prior to transplantation, if they are found suitable for transplantation after reassessment.

For detailed information please CLICK HERE

USFDA CDRH Medical Device Class I Recall Alert - Cook CloverSnare 4-Loop Vascular Retrieval Snare

Product:  CloverSnare 4-Loop Vascular Retrieval Snare
  • Model Number VRS-6.0-90
  • Manufacturing Dates: August 2012 – August 2013
  • Distribution Dates: March 8, 2013 – July 1, 2014
  • Complete Listing of Affected Lot Numbers
  • 671 devices have been distributed nationwide
Use: The CloverSnare 4-Loop Vascular Retrieval Snare is used to manipulate and retrieve items in the cardiovascular system, such as temporary implanted devices. This includes inferior vena cava filters or broken devices (e.g., guidewires, coils, balloons, and catheters).
Recalling Firm: 
Cook Inc. 
750 N Daniels Way
Bloomington, Indiana 47404-9120
Reason for Recall: There is a potential for the snare loop to separate from the shaft.  If this occurs, the snare loop may travel through the vascular system and block blood vessels or become stuck in other organs, such as the heart and lungs. Additional intervention may be necessary to retrieve the separated snare loop from the patient.  This failure will also cause the device to stop working.  Four injuries have been reported.
The use of the affected product may cause serious adverse health consequences, including death.
On July 17, 2014, Cook Medical sent customers an Urgent Medical Device Recall letter informing them of the product, problem and actions to be taken.  The firm requested customers:
  • Separate any affected unused products from inventory. 
  • Collect and return all unused products to Cook Medical as soon as possible for credit.
  • Complete and return the Recalled Product Reply Form to Cook Medical, separately or when returning the product.
About Class I Recalls
Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these products to MedWatch: The FDA Safety Information and Adverse Event Reporting Program either online, by regular mail or by FAX.

Guidance for Industry: CDRH - Highly Multiplexed Microbiological/Medical Countermeasure In Vitro Nucleic Acid Based Diagnostic Devices



A guidance document titled, "Highly Multiplexed Microbiological/Medical Countermeasure In Vitro Nucleic Acid Based Diagnostic Devices" has recently been posted.  

This document recommends studies for establishing the performance characteristics of HMMDs. 

FDA considers these recommended studies to be relevant for premarket notifications (e.g., 510(k) or de novo) that may be required for a particular device.  

To view the guidance, please CLICK HERE

USFDA: New Medical Device Approval - SenoClaire

The FDA has recently approved SenoClaire to be marketed.  

SenoClaire is a mammography device that produces 2D digital images as well as multiple cross-sectional images of the breast for the screening and diagnosis of breast cancer.  

For more information, please click here

USFDA: Recall: CloverSnare™ 4-Loop Vascular Retrieval Snare Recall

On July 10, 2014, Cook Medical initiated a recall of 696 of its CloverSnare™ 4-Loop Vascular Retrieval Snare devices. The device was recalled because of a potential for the loop to separate from the shaft, resulting in loss of device function, potential for embolization of snare fragments and the potential need for intervention to retrieve the separated snare. 

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click CloverSnare™ 4-Loop Vascular Retrieval Snare Recall

USFDA: CDRH Industry: Announcing Final Guidance and FDA Webinar on Evaluation of Sex-Specific Data in Medical Device Clinical Studies

Today the Food and Drug Administration (FDA) posted a final guidance document, “Evaluation of Sex-Specific Data in Medical Device Clinical Studies.” in combination with the FDASIA Section 907 Action Plan. The FDA’s final guidance outlines specific recommendations for considering sex and other variables during the study design stage, to improve consistency of analysis and reporting of information on demographics in labeling and other public documents. The action plan focuses on three over-arching priorities: Data Quality, Subgroup Participation, and Data Transparency. 
Certain medical products may elicit different responses in women than men and these variables may affect the safe and effective use of medical devices. The FDA’s final guidance outlines specific recommendations for considering sex and other variables during the study design stage, to improve consistency of analysis and reporting of information on demographics in labeling and other public documents.

The final guidance provides recommendations to medical device industry and FDA staff on:
  • Enrollment: Recommended methods for designing and conducting clinical studies to encourage enrollment of both sexes.
  • Analysis: Recommended methods for analysis of demographic data.
  • Reporting: Recommended approaches for reporting of demographic data for device studies in the labeling and other public documents for approved or cleared devices.
  • Decision frameworks for sex-specific study design, and for considering sex-specific data when analyzing and interpreting overall study outcomes, including when additional data may be needed.
On August 25, 2014 the FDA will hold a webinar to explain the guidance and to provide an opportunity to ask questions.  Registration is not necessary.

Webinar Details:
Date: August 25, 2014
Time: 3:00 PM – 4:30 PM, Eastern Time
To ensure you are connected, log-in at 2:45 PM.

To hear the presentation and ask questions:  
Dial: 1-888-282-0359; passcode: 7984204

To view the slide presentation during the webinar: https://www.mymeetings.com/nc/join/
Conference number: PW8306676 
Passcode: 798204

Following the webinara transcript, recording and slides will be available at: http://www.fda.gov/Training/CDRHLearn/default.htm
Please Note: the slide presentation will also be available at this site on the morning of the webinar.
  

If you have any questions regarding this guidance, please contact one of the following at FDA/CDRH:


Food and Drug Administration
Center for Devices and Radiological Health